Topics
Gliomas | Treatment | Targeted therapy | Larotrectinib
Home > Publications > Topics > Gliomas > Treatment > Targeted therapy > Larotrectinib
Chen Y, Ma J, Gao Q, Gai Y, Sun Y, Wang M.
Larotrectinib
versus infigratinib for adult patients with both glioma and
tyrosine kinase alterations after failure of initial therapies:
Efficacy and safety analysis.
Clinics
(Sao Paulo). 2024 Feb 7;79:100329. doi:
10.1016/j.clinsp.2024.100329. PMID:
38330791. Observational
study.
ˍ